Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
4
×
san francisco blog main
startups
cancer
deals
gilead sciences
hepatitis b
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
abbvie
adeno-associated virus
allergan aesthetics
alnylam pharmaceuticals
alzheimer's disease
amgen
astrazeneca
athira pharma
attralus
beijing
biobucks
biontech
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
brii bio
brii biosciences
calistoga pharmaceuticals
cancer drugs
car-t immunotherapy
checkpoint inhibitors
What
pipeline
4
×
drug
adding
build
gilead
medicines
million
sciences
therapeutics
acquisitions
adds
ago
aiming
alliance
areas
balance
bets
biggest
bio
biosciences
bio’s
boost
brii
buy
cancer
ceo
company’s
daniel
debut
decibel
disease
drugs
dyne’s
earlier
emerged
expensive
far
focus
forms
hearing
Language
unset
Current search:
pipeline
×
" national top stories "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango